|View printer-friendly version|
The conference call dial-in numbers are (855) 867-4103 (
A live webcast of the call will also be available from the Investor Relations section of the Company's website at www.accuray.com/investors. A webcast replay can be accessed on the website and will remain available until
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/accuray-to-report-fiscal-2016-first-quarter-financial-results-on-october-29-2015-300156217.html
Doug Sherk, Investor Relations, EVC Group, +1 (415) 652-9100, email@example.com, Beth Kaplan, Public Relations Director, Accuray, +1 (408) 789-4426, firstname.lastname@example.org
© 2007 - 2016 Accuray Incorporated. All Rights Reserved. Accuray, the stylized logo, CyberKnife, TomoTherapy, Synchrony, Xsight, Xchange, TomoHD, Hi-Art, and RoboCouch are among the trademarks and / or registered trademarks of Accuray Incorporated in the United States and other countries.
Important Safety Information: Most side effects of radiotherapy, including radiotherapy delivered with Accuray systems, are mild and temporary, often involving fatigue, nausea, and skin irritation. Side effects can be severe, however, leading to pain, alterations in normal body functions (for example, urinary or salivary function), deterioration of quality of life, permanent injury and even death.
Side effects can occur during or shortly after radiation treatment or in the months and years following radiation. The nature and severity of side effects depend on many factors, including the size and location of the treated tumor, the treatment technique (for example, the radiation dose), the patient's general medical condition, to name a few. For more details about the side effects of your radiation therapy, and if treatment with an Accuray product is right for you, ask your doctor.